CoAprovel 150/12.5
CoAprovel 150/12.5 is a medicine authorised by Swissmedic under authorisation number 54842. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 February 1999 and the authorisation is valid without a time limit. ATC code C09DA04 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 54842 |
|---|---|
| Name | CoAprovel 150/12.5 |
| Full name | CoAprovel 150/12.5, comprimés filmés |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DA04 |
| First authorisation | 10 February 1999 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | CoAprovel 150/12.5, comprimés filmés | B | 10 February 1999 |
| 2 | CoAprovel 300/12.5, comprimés filmés | B | 10 February 1999 |
| 3 | CoAprovel 300/25, comprimés filmés | B | 19 December 2006 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 66 | 28 | Tablette(n) | C09DA04 | 02.07.2. | B |
| 74 | 98 | Tablette(n) | C09DA04 | 02.07.2. | B |
| 82 | 28 | Tablette(n) | C09DA04 | 02.07.2. | B |
| 90 | 98 | Tablette(n) | C09DA04 | 02.07.2. | B |
| 104 | 28 | Tablette(n) | C09DA04 | 02.07.2. | B |
| 112 | 98 | Tablette(n) | C09DA04 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is CoAprovel 150/12.5 authorised in Switzerland?
Yes. CoAprovel 150/12.5 is authorised by Swissmedic under authorisation number 54842, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does CoAprovel 150/12.5 have?
CoAprovel 150/12.5 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of CoAprovel 150/12.5?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.